Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | %Female (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 9.152 Q1 | 254 | 26 | 105 | 12841 | 2372 | 105 | 19.35 | 493.88 | 20.66 | |
2 | Pharmacology and Therapeutics | journal | 4.048 Q1 | 233 | 107 | 314 | 21251 | 3282 | 313 | 11.04 | 198.61 | 37.95 | |
3 | Medicinal Research Reviews | journal | 2.534 Q1 | 150 | 39 | 97 | 6938 | 826 | 96 | 8.89 | 177.90 | 38.99 | |
4 | Reviews of Physiology Biochemistry and Pharmacology | journal | 2.812 Q1 | 70 | 8 | 15 | 1415 | 101 | 15 | 6.73 | 176.88 | 31.03 | |
5 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.137 Q1 | 82 | 15 | 38 | 2511 | 166 | 38 | 5.15 | 167.40 | 40.91 | |
6 | Drug Metabolism Reviews | journal | 1.633 Q1 | 108 | 30 | 89 | 4924 | 501 | 85 | 5.51 | 164.13 | 45.19 | |
7 | Pharmaceutical Crops | journal | 1 | 1 | 0 | 158 | 0 | 0 | 0.00 | 158.00 | 50.00 | ||
8 | Advanced Drug Delivery Reviews | journal | 4.877 Q1 | 366 | 137 | 462 | 20537 | 7760 | 413 | 15.63 | 149.91 | 32.82 | |
9 | Critical Reviews in Toxicology | journal | 1.664 Q1 | 129 | 48 | 125 | 7062 | 750 | 112 | 5.07 | 147.13 | 32.57 | |
10 | Natural Product Reports | journal | 3.420 Q1 | 211 | 92 | 218 | 12958 | 2322 | 213 | 9.86 | 140.85 | 28.03 | |
11 | Perspectives in Medicinal Chemistry | journal | 0.108 Q4 | 17 | 5 | 2 | 700 | 0 | 2 | 0.00 | 140.00 | 30.00 | |
12 | Advances in Pharmacology | journal | 2.233 Q1 | 86 | 46 | 104 | 6266 | 512 | 0 | 4.61 | 136.22 | 0.00 | |
13 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.793 Q1 | 99 | 15 | 61 | 1958 | 365 | 56 | 5.14 | 130.53 | 46.38 | |
14 | Annual Review of Pharmacology and Toxicology | journal | 9.351 Q1 | 224 | 27 | 71 | 3483 | 1457 | 70 | 20.74 | 129.00 | 19.74 | |
15 | Journal of Receptor, Ligand and Channel Research | journal | 0.195 Q3 | 13 | 9 | 9 | 1155 | 6 | 8 | 0.75 | 128.33 | 34.62 | |
16 | Current Drug Metabolism | journal | 1.014 Q2 | 122 | 70 | 329 | 8760 | 1127 | 291 | 3.23 | 125.14 | 37.41 | |
17 | Handbook of Experimental Pharmacology | journal | 1.647 Q1 | 110 | 118 | 361 | 13886 | 1463 | 340 | 3.80 | 117.68 | 36.33 | |
18 | Cellular and Molecular Life Sciences | journal | 3.454 Q1 | 261 | 311 | 891 | 35012 | 5773 | 885 | 6.10 | 112.58 | 43.75 | |
19 | Progress in Medicinal Chemistry | journal | 1.293 Q1 | 38 | 5 | 17 | 534 | 61 | 1 | 3.27 | 106.80 | 0.00 | |
20 | Molecular and Cellular Pharmacology | journal | 0.758 Q1 | 28 | 3 | 42 | 314 | 78 | 39 | 0.65 | 104.67 | 61.54 | |
21 | Cancer Therapy | journal | 0.221 Q3 | 9 | 4 | 14 | 408 | 19 | 14 | 0.18 | 102.00 | 30.00 | |
22 | Nanotechnology, Science and Applications | journal | 1.131 Q1 | 35 | 6 | 18 | 604 | 116 | 18 | 7.63 | 100.67 | 14.29 | |
23 | Drug Resistance Updates | journal | 3.578 Q1 | 132 | 9 | 63 | 904 | 687 | 59 | 10.06 | 100.44 | 34.21 | |
24 | Expert Opinion on Drug Discovery | journal | 1.154 Q1 | 84 | 107 | 285 | 10590 | 1006 | 285 | 3.79 | 98.97 | 33.58 | |
25 | Expert Opinion on Therapeutic Targets | journal | 1.990 Q1 | 106 | 116 | 380 | 11340 | 1797 | 367 | 4.78 | 97.76 | 38.19 | |
26 | Journal of Biomedical Nanotechnology | journal | 0.750 Q1 | 93 | 261 | 524 | 25186 | 2470 | 521 | 5.56 | 96.50 | 39.55 | |
27 | Expert Opinion on Emerging Drugs | journal | 0.982 Q2 | 54 | 41 | 129 | 3944 | 391 | 126 | 3.18 | 96.20 | 35.20 | |
28 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.906 Q2 | 100 | 127 | 375 | 11853 | 1234 | 373 | 3.30 | 93.33 | 36.29 | |
29 | Neurotherapeutics | journal | 2.433 Q1 | 136 | 79 | 206 | 7345 | 1133 | 193 | 5.41 | 92.97 | 40.59 | |
30 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.172 Q3 | 29 | 10 | 36 | 877 | 28 | 0 | 0.72 | 87.70 | 0.00 | |
31 | Expert Review of Vaccines | journal | 1.533 Q1 | 105 | 167 | 459 | 14550 | 1767 | 393 | 3.85 | 87.13 | 42.92 | |
32 | Clinical Medicine Insights: Therapeutics | journal | 0.152 Q3 | 11 | 4 | 79 | 348 | 27 | 79 | 0.49 | 87.00 | 14.29 | |
33 | Vaccines | journal | 0.123 Q4 | 85 | 42 | 2 | 3639 | 0 | 1 | 0.00 | 86.64 | 45.03 | |
34 | Expert Opinion on Therapeutic Patents | journal | 1.310 Q1 | 88 | 102 | 324 | 8692 | 1270 | 323 | 4.42 | 85.22 | 32.77 | |
35 | Expert Opinion on Drug Delivery | journal | 1.423 Q1 | 133 | 144 | 357 | 12018 | 1870 | 351 | 5.12 | 83.46 | 33.40 | |
36 | Nano Today | journal | 7.152 Q1 | 175 | 68 | 192 | 5667 | 2426 | 121 | 9.81 | 83.34 | 29.65 | |
37 | Expert Opinion on Investigational Drugs | journal | 1.431 Q1 | 117 | 140 | 442 | 11529 | 1741 | 434 | 4.18 | 82.35 | 39.36 | |
38 | Current Pharmaceutical Biotechnology | journal | 1.005 Q1 | 97 | 131 | 630 | 10371 | 1751 | 573 | 2.42 | 79.17 | 40.00 | |
39 | Neuropharmacology | journal | 2.410 Q1 | 191 | 423 | 1166 | 32705 | 6304 | 1145 | 5.65 | 77.32 | 42.61 | |
40 | Frontiers in Pharmacology | journal | 1.560 Q1 | 154 | 272 | 444 | 20945 | 1872 | 425 | 4.14 | 77.00 | 41.61 | |
41 | Inflammation and Allergy - Drug Targets | journal | 0.814 Q2 | 55 | 43 | 178 | 3300 | 417 | 163 | 2.14 | 76.74 | 43.61 | |
42 | British Journal of Pharmacology | journal | 2.202 Q1 | 244 | 425 | 1453 | 32394 | 7579 | 1413 | 5.08 | 76.22 | 38.07 | |
43 | Pharmacological Research | journal | 2.031 Q1 | 169 | 106 | 428 | 7971 | 2258 | 416 | 5.49 | 75.20 | 40.60 | |
44 | Trends in Pharmacological Sciences | journal | 5.062 Q1 | 244 | 83 | 268 | 6223 | 2661 | 236 | 10.22 | 74.98 | 28.14 | |
45 | Journal of NeuroImmune Pharmacology | journal | 1.587 Q1 | 91 | 58 | 266 | 4312 | 947 | 255 | 4.09 | 74.34 | 44.09 | |
46 | Journal of Pharmacy and Pharmaceutical Sciences | journal | 0.652 Q1 | 88 | 38 | 145 | 2768 | 369 | 145 | 2.30 | 72.84 | 33.14 | |
47 | Expert Opinion on Biological Therapy | journal | 1.326 Q1 | 102 | 162 | 487 | 11723 | 1875 | 476 | 3.97 | 72.36 | 35.19 | |
48 | Pharmacogenomics and Personalized Medicine | journal | 0.901 Q2 | 37 | 36 | 38 | 2605 | 124 | 38 | 3.41 | 72.36 | 47.15 | |
49 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.789 Q1 | 150 | 187 | 723 | 13392 | 3205 | 677 | 4.22 | 71.61 | 40.40 | |
50 | Pharmaceutical Nanotechnology | journal | 22 | 5 | 0 | 357 | 0 | 0 | 0.00 | 71.40 | 47.06 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®